3rd International Conference on Otorhinolaryngology Research and Treatment

This session will explore the complex relationship between parathyroid disease and pregnancy, focusing on the implications for both maternal and fetal health. Parathyroid disorders, including primary hyperparathyroidism and hypoparathyroidism, can significantly impact calcium metabolism, which is critical during pregnancy. Understanding these conditions is essential for managing the unique physiological changes that occur during this period. Key topics will include the effects of hyperparathyroidism on pregnancy outcomes, such as increased risk of pregnancy complications, including hypertension and fetal growth restriction. The session will discuss the pathophysiology of parathyroid disease, including the role of parathyroid hormone in regulating calcium and its implications for maternal and fetal calcium levels. Management strategies for pregnant patients with parathyroid disease will be a focal point, emphasizing the importance of a multidisciplinary approach involving endocrinologists, obstetricians, and pediatricians. Guidelines for the safe management of hyperparathyroidism during pregnancy, including the timing of surgery and medical management options, will be reviewed.

Recent research has advanced our understanding of the interplay between parathyroid disease and pregnancy, highlighting important implications for maternal and fetal health. One significant development is the growing recognition of the risks associated with primary hyperparathyroidism (PHPT) during pregnancy. Studies have shown that untreated PHPT can lead to adverse outcomes, including gestational hypertension, preeclampsia, and fetal growth restriction. As a result, many experts advocate for the careful monitoring of calcium levels and parathyroid hormone (PTH) levels throughout pregnancy. Another recent development involves the management of parathyroid disease during pregnancy. Current guidelines suggest a multidisciplinary approach, involving endocrinologists and obstetricians, to tailor treatment strategies that balance maternal health with fetal safety. Surgical intervention for PHPT is being considered earlier in pregnancy than previously recommended, especially when there are severe symptoms or complications. Furthermore, minimally invasive surgical techniques have shown promise in reducing recovery times and minimizing risks associated with surgery during pregnancy.

Discuss the implications of hyperthyroidism in pregnant patients, including potential complications for both mother and fetus, management strategies, and the impact of antithyroid medications on pregnancy outcomes.

Explore the effects of hypothyroidism during pregnancy, focusing on diagnosis, treatment options, and the importance of maintaining appropriate thyroid hormone levels to ensure healthy fetal development and maternal well-being.

Examine the role of thyroiditis, particularly Hashimoto’s thyroiditis, in pregnancy, including its impact on thyroid function, management strategies, and potential complications that may arise during gestation.

Investigate the relationship between thyroid disorders and obstructive sleep apnea (OSA), discussing the indications and outcomes of surgical interventions for snoring and OSA in pregnant patients.

Review congenital Graves’ disease, its etiology, diagnosis, and management in infants born to mothers with hyperthyroidism, including the implications for maternal health during pregnancy.

Focus on the management of maternal hypothyroidism during pregnancy, including the challenges of medication adjustment and monitoring, and the potential effects on pregnancy outcomes.

Explore the incidence and management of postpartum thyroid dysfunction, including thyroiditis and the transition between hyperthyroid and hypothyroid states following childbirth.

Discuss the implications of thyroid-related eye disease in pregnant patients, including its association with Graves’ disease, management approaches, and the impact on quality of life during and after pregnancy.